Sezgi Nur Dogan

Dr. Sezgi Nur Dogan

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 November 2025 in Strabismus
Verified
Journal Article
Closed access
AKAlev Koçkar
Alev Koçkar
AYAslı Çetinkaya Yaprak
Aslı Çetinkaya Yaprak
SDSezgi Nur Dogan
Sezgi Nur Dogan
OÖOzan Özgül
Ozan Özgül
To evaluate the long-term efficacy of botulinum toxin A (BoNT-A) in children with acute acquired comitant esotropia (AACE). This retrospective study included pediatric patients treated with BoNT-A for AACE between January 2021 and September 2024. Deviation angles at near (40 cm) and distance (5 m) were recorded before treatment and at 1, 3, 6, 12 months, and final follow-up. Outcomes were categorized as successful (≤10 prism diopters [PD]), partially successful (11-20 PD), or unsuccessful ( >20 PD). Twenty patients (mean age 5 ± 1 years; 65% female) were included. BoNT-A was administered a mean of 4 ± 2 weeks after symptom onset. A second injection was required in 35% of patients. At final follow-up (mean: 20.4 ± 12.0 months), mean near and distance deviations were 8 ± 17 PD and 10 ± 17 PD, respectively. Thirteen patients (65%) had successful outcomes, four (20%) were partially successful, and three (15%) were unsuccessful. Patients receiving a single injection had significantly better outcomes than those requiring a second (p = .041). Mild, self-resolving ptosis occurred in two cases (10%). Early treatment with BoNT-A provides a high rate of motor alignment in pediatric AACE and may reduce the need for surgery. These results support its use as an effective first-line treatment option.

26 May 2026 in Applied Sciences
Verified
Journal Article
Open access
PDF file
AKAlev Koçkar
Alev Koçkar
AOAhmet Oran
Ahmet Oran
SDSezgi Nur Dogan
Sezgi Nur Dogan
BABetül İlkay Sezgin Akçay
Betül İlkay Sezgin Akçay
Background/Objectives: To evaluate the numerical agreement and variability between large language model (LLM)-generated surgical dosage recommendations and expert surgical planning in strabismus surgery under controlled conditions. Methods: This retrospective, single-center study included patients who underwent horizontal strabismus surgery between January 2023 and May 2025 and achieved successful postoperative alignment (≤±10 prism diopters at 3 months). Standardized preoperative clinical data were provided to three LLMs (ChatGPT-5.2, Gemini 3.0 Pro, and DeepSeek v3.2), each prompted to generate surgical dosage recommendations in millimeters. Model outputs were compared with the surgeon’s preoperative plans. Agreement and variability were assessed using intraclass correlation coefficients (ICC) and Bland–Altman analyses. Results: A total of 68 patients were included (44.1% female; mean age 11.7 ± 10.5 years). Agreement between LLM-generated and surgeon-determined surgical dosages was heterogeneous across models and surgical subtypes. Moderate ICC values were observed in selected subgroups; however, confidence intervals were frequently wide and, in several instances, crossed zero, indicating limited statistical reliability. Bland–Altman analyses demonstrated wide limits of agreement, often approaching or exceeding ±1 mm. Agreement tended to be higher in smaller deviation angles (≤35 prism diopters) and lower in larger deviations and more complex surgical scenarios. Conclusions: LLM-generated surgical dosage recommendations demonstrated variable and context-dependent agreement with expert planning, with substantial variability and limited reliability across subgroups. These findings indicate that current LLM-based systems do not achieve the level of precision required for quantitative surgical decision-making and should be considered investigational and not suitable for independent clinical use. This study represents a variability and calibration analysis rather than an evaluation of clinical accuracy or decision-making performance.